Regional Differences in the Permeability Barrier of the Skin-Implications in Acantholytic Skin Diseases.
Darier’s disease
Hailey–Hailey disease
acantolytic diseases
barrier function
cornified envelope
desmosome
keratinocyte
tight junction
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
27 Sep 2021
27 Sep 2021
Historique:
received:
13
08
2021
revised:
15
09
2021
accepted:
23
09
2021
entrez:
13
10
2021
pubmed:
14
10
2021
medline:
28
10
2021
Statut:
epublish
Résumé
The chemical milieu, microbiota composition, and immune activity show prominent differences in distinct healthy skin areas. The objective of the current study was to compare the major permeability barrier components (stratum corneum and tight junction (TJ)), investigate the distribution of (corneo)desmosomes and TJs, and measure barrier function in healthy sebaceous gland-rich (SGR), apocrine gland-rich (AGR), and gland-poor (GP) skin regions. Molecules involved in cornified envelope (CE) formation, desquamation, and (corneo)desmosome and TJ organization were investigated at the mRNA and protein levels using qRT-PCR and immunohistochemistry. The distribution of junction structures was visualized using confocal microscopy. Transepidermal water loss (TEWL) functional measurements were also performed. CE intracellular structural components were similarly expressed in gland-rich (SGR and AGR) and GP areas. In contrast, significantly lower extracellular protein levels of (corneo)desmosomes (DSG1 and CDSN) and TJs (OCLN and CLDN1) were detected in SGR/AGR areas compared to GP areas. In parallel, kallikrein proteases were significantly higher in gland-rich regions. Moreover, gland-rich areas were characterized by prominently disorganized junction structures ((corneo)desmosomes and TJs) and significantly higher TEWL levels compared to GP skin, which exhibited a regular distribution of junction structures. According to our findings, the permeability barrier of our skin is not uniform. Gland-rich areas are characterized by weaker permeability barrier features compared with GP regions. These findings have important clinical relevance and may explain the preferred localization of acantholytic skin diseases on gland-rich skin regions (e.g., Pemphigus foliaceus, Darier's disease, and Hailey-Hailey disease).
Identifiants
pubmed: 34638769
pii: ijms221910428
doi: 10.3390/ijms221910428
pmc: PMC8509001
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Hungarian Scientific Research Fund
ID : NKFIH K-128250
Organisme : Hungarian Scientific Research Fund
ID : NKFIH PD-131689
Organisme : European Union and the European Social Fund
ID : EFOP-3.6.1-16-2016-00022
Organisme : János Bolyai Research Scholarship of the Hungarian Academy of Sciences
ID : bo_39_19
Organisme : New National Excellence Program of the Ministry for Innovation and Technology
ID : ÚNKP-20-5
Références
Nat Rev Microbiol. 2018 Mar;16(3):143-155
pubmed: 29332945
Br J Dermatol. 2004 May;150(5):821-8
pubmed: 15149492
J Allergy Clin Immunol. 2016 Aug;138(2):350-358.e1
pubmed: 27497277
Med Mol Morphol. 2011 Mar;44(1):1-6
pubmed: 21424930
Cell Tissue Res. 2013 Feb;351(2):325-37
pubmed: 22358849
Hum Mol Genet. 2000 Apr 12;9(7):1131-40
pubmed: 10767338
Allergol Int. 2018 Jan;67(1):3-11
pubmed: 29153780
Exp Dermatol. 2019 Aug;28(8):877-885
pubmed: 30972831
Front Immunol. 2018 Mar 05;9:424
pubmed: 29556238
Br J Dermatol. 2019 Jun;180(6):1498-1505
pubmed: 30585310
Nat Rev Microbiol. 2011 Apr;9(4):244-53
pubmed: 21407241
J Invest Dermatol. 2011 Feb;131(2):285-7
pubmed: 21228809
Lancet. 2019 Sep 7;394(10201):882-894
pubmed: 31498102
Br J Dermatol. 2005 Aug;153(2):274-81
pubmed: 16086736
J Allergy Clin Immunol. 2018 Jul;142(1):281-284.e7
pubmed: 29382595
Biochim Biophys Acta. 2011 May;1813(5):1111-7
pubmed: 21167218
Skin Pharmacol Physiol. 2012;25(1):25-33
pubmed: 21912200
J Dermatol Sci. 2019 Aug;95(2):50-55
pubmed: 31279501
J Invest Dermatol. 2017 May;137(5):1114-1125
pubmed: 28131815
J Invest Dermatol. 2019 Apr;139(4):964-968
pubmed: 30391261
J Med Microbiol. 2020 Mar;69(3):436-442
pubmed: 32068525
Cold Spring Harb Perspect Med. 2014 Aug 01;4(8):
pubmed: 25085959
J Invest Dermatol. 2010 Feb;130(2):614-7
pubmed: 19812593
J Invest Dermatol. 2007 Mar;127(3):510-2
pubmed: 17299432
Clin Dermatol. 2010 Jan-Feb;28(1):2-7
pubmed: 20082942
J Invest Dermatol. 2017 Feb;137(2):377-384
pubmed: 27765722
Science. 2014 Nov 21;346(6212):954-9
pubmed: 25414304
J Invest Dermatol. 2014 Jul;134(7):1961-1970
pubmed: 24390139
J Invest Dermatol. 2001 Jul;117(1):91-7
pubmed: 11442754
J Invest Dermatol. 2008 Apr;128(4):917-25
pubmed: 17943185
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):E2120-9
pubmed: 25825778
J Invest Dermatol. 2006 Apr;126(4):925-9
pubmed: 16456535
Nat Rev Mol Cell Biol. 2005 Apr;6(4):328-40
pubmed: 15803139
J Invest Dermatol. 2008 Jan;128(1):18-25
pubmed: 17625593
Front Microbiol. 2019 Mar 05;10:413
pubmed: 30891022
Br J Dermatol. 2017 Jan;176(1):145-158
pubmed: 27442805
Nat Rev Dis Primers. 2017 May 11;3:17026
pubmed: 28492232